Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

Conditions

• SCS

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Accepted

Interventions

• SCS — DEVICE
  Conventional SCS implants approved through all payors(government and private) for FDA approved indications

Study Details

The objective is to provide information to help the physician community decide the most effective type of device/therapy that would work for their patients, based off of the etiology of pain, the location of the pain for sustained pain relief.

Key Dates

Start date

Nov 1, 2020

Status verified

Aug 2024

Primary completion

Nov 1, 2026

Completion

Nov 1, 2026

Study Design

Enrollment

500 participants (estimated)

Primary Outcome Measure

Change in pain relief [ Time Frame: 12 months ]

Central Contacts

• tom Gordon
  (513) 619-1683
  [email protected]

Locations (1)

Find similar trials in Reno, NV